JH
Jonathan Robert Hunt
Chief Accounting Officer

Jonathan Robert Hunt insider trades: Perspective Therapeutics (CATX) stock purchases

Chief Accounting Officer, Perspective Therapeutics Last trade Nov 13, 2025 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$22K
Bought, last 12 months
1 buy
8
Open-market trades
since 2020
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jonathan reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 13, 2025CATX↑ Buy$22K
Nov 25, 2024CATX↑ Buy$49K
Jun 17, 2024CATX↑ Buy$18K
May 31, 2024CATX↑ Buy$35K
Dec 18, 2023CATX↑ Buy$32K
Dec 5, 2022ISR↑ Buy$33K
Jun 8, 2022ISR↑ Buy$11K
Oct 22, 2020ISR↑ Buy$35K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CATX insiders

Open-market trades in the last 12 months

About Jonathan Robert Hunt's insider trades

Jonathan Robert Hunt is Chief Accounting Officer at Perspective Therapeutics (CATX). Since Oct 22, 2020, Jonathan has reported 8 open-market purchases worth $235K and no sales on SEC Form 4. In the last 12 months: 1 buy ($22K).

Their filings also include grants and awards (13 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CATX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.